13 Aug 2021 10:35
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | (GS) GOLDMAN SACHS INTERNATIONAL |
Company dealt in | UDG HEALTHCARE PLC |
Class of relevant security to which the dealings being disclosed relate (Note1) | EUR 0.05 ordinary shares |
Date of dealing | 12 August 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
149,608 | 10.7896 GBP | 10.7850 GBP |
Total number of relevant securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
20,097 | 10.7850 GBP | 10.7800 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
CFD | Reducing a short position | 793 | 10.7800 GBP |
CFD | Increasing a short position | 50,000 | 10.7882 GBP |
CFD | Increasing a short position | 80,304 | 10.7895 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name,e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name,e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
NONE |
Date of disclosure | 13 August 2021 |
Contact name | Paul Grainger and Kashif Rafiq |
Telephone number | +44(20) 7552 9835 / +44(20) 7051 0547 |
Name of offeree/offeror with which connected | UDG HEALTHCARE PLC |
Nature of connection (Note 6) | Advisor to Offeree |